Curia
Curia is an end-to-end Contract Research, Development and Manufacturing Organization (CRDMO) with expertise in biologics and small molecule drugs gained over decades serving pharmaceutical and biotechnology companies. Our teams offer a comprehensive suite of services from discovery to manufacturing of mRNA therapeutics, including vector engineering, linearized plasmid production suitable for manufacturing, process development, drug substance manufacturing, lipid synthesis, LNP-mRNA formulation, drug product fill/finish, analytics and quality control assays.
We have experience with both non-replicating and self-amplifying mRNAs and have synthesized molecules larger than 16 kb at scales ranging from milligram to multigram quantities. Single-use technologies and animal component-free raw materials are important elements of our manufacturing processes. Our comprehensive suite of on-site analytics and quality control assays streamline process development and batch release.
